1. Introduction {#sec1}
===============

Hypercalcemia is a common clinical problem with an estimated prevalence of 15% among hospitalized patients \[[@B1]\]. The etiology of hypercalcemia is complex with many factors playing a pathogenic role. From a clinical standpoint, it may present with changes in mental status, generalized weakness, polyuria, and constipation. Multiple myeloma (MM) and primary hyperparathyroidism (PHPT) are among the most common causes of hypercalcemia but coexistence of the two pathologic processes in one patient is an extremely rare phenomenon. In this paper, we have discussed a patient presenting with this rare phenomenon and have reviewed the relevant scientific literature.

2. Case Presentation {#sec2}
====================

A 92-year-old Caucasian female with a past medical history of Alzheimer\'s dementia, seizure disorder, osteoporosis, and osteoarthritis was admitted to the hospital for an evaluation of a new onset confusion and constipation. Review of symptoms during admission was significant for anorexia, weight loss, constipation for the last three weeks, and history of a fall one month prior to the presentation. Family history was significant for MM in a sister. At the time of presentation, the patient was using donepezil, memantine, vitamin D with calcium, calcium carbonate (calcium containing antacid), and levetiracetam. Vitals at the time of admission were blood pressure 140/58, pulse 68, respiratory rate 18, oxygen saturation 98% on room air, and temperature 97.4. On physical examination, the patient was alert and oriented in place and person but not in time. Other significant findings were diastolic murmur in right second intercostal space, petechiae over lower extremities, and back tenderness, which the patient attributed to a recent fall. Lumbar spine X-ray was done three weeks prior to the presentation that showed degenerative changes with no evidence of fracture. Basic blood workup including complete blood count and comprehensive metabolic panel was done, which revealed anemia, leucopenia, and hypercalcemia. Home medications were held for concerns of hypercalcemia and confusion.

Endocrinology and neurology services were consulted. MRI of the brain was done, which showed lytic lesions as shown in [Figure 1](#fig1){ref-type="fig"}. MM was suspected; serum protein electrophoresis (SPEP), urine protein electrophoresis (UPAP) and bone marrow biopsy were done which confirmed the diagnosis of MM (IgG kappa) (International Staging System stage II). Bone marrow biopsy showed mildly hypercellular bone marrow with plasmacytosis (30%) as shown in [Figure 2](#fig2){ref-type="fig"}. Skeletal survey showed diffuse lytic lesions throughout long bones, pelvis, and skull ([Figure 3](#fig3){ref-type="fig"}). Surprisingly, intact PTH came back high suggesting primary hyperparathyroidism (PHPT). The data on laboratory tests are presented in [Table 1](#tab1){ref-type="table"}.

Hypercalcemia was managed with intravenous hydration, calcitonin, bisphosphonates, and furosemide. The patient was started on melphalan and prednisone, which were later switched to lenalidomide with a high dose of dexamethasone due to a poor treatment response. After one and a half year, the patient is still following in our outpatient oncology center being on a low dose of lenalidomide with a stable M protein.

3. Discussion {#sec3}
=============

Hypercalcemia is common in patients with MM and occurs in 28% of myeloma cases \[[@B2]\]. MM may cause hypercalcemia through multiple mechanisms. First, plasma cells produce various cytokines, including TNF-*β* and IL-6, that activate osteoclasts and lead to calcium washout from bones to the bloodstream \[[@B3]\]. Second, some studies suggest that MM cells may secrete parathyroid hormone-related peptide similarly to other malignancies, such as squamous cell lung carcinoma \[[@B4], [@B5]\]. Third, serum calcium may be falsely elevated because of a binding to immunoglobulin \[[@B6], [@B7]\].

Clubb et al. \[[@B8]\] described first-case linking PHPT and paraproteinemia in 1964. Drezner and Lebovitz were the first who described a case of concomitant MM and PHPT in 1979 \[[@B9]\]. Some researchers speculate that the association between MM and PHTP may not be coincidental \[[@B10], [@B11]\], although mechanisms explaining codiagnosis are not known. Arnulf et al. showed that the prevalence of monoclonal gammopathy is higher in patients with PHTP as compared to general population \[[@B11]\]. Pest et al. hypothesized that elevated PTH may mediate the induction of MM through the downstream biological effects of IL-6 \[[@B12]\]. This hypothesis was supported by the study performed by Pirih et al., who showed that PTH decreases apoptotic cell death of the hematopoietic stem cells via the IL-6 \[[@B13]\].

PHPT leads to hypercalcemia via direct bone resorption \[[@B14]\] mediated by osteoclasts. Another important mechanism is through an increased calcium absorption in the duodenum and greater reabsorption in the kidneys.

The above-mentioned pathogenic mechanism gives an insight to how PHPT and MM may be linked. Some studies have suggested that calcium may act as a mitogenic factor \[[@B15]\], whereas others suggest that myelomatous proteins may interfere with polypeptide hormone synthesis bind their circulating fractions, and/or block their peripheral effects that may secondarily stimulate parathyroid gland \[[@B16]\]. However, both of these diseases are common among elderly and may share similar risk factors, such as ionizing radiation \[[@B17], [@B18]\], and a simple coincidence may be the case.

Summary of published cases \[[@B12]--[@B45]\] is presented in [Table 2](#tab2){ref-type="table"}. Codiagnosis of PHPT and MM should be suspected in cases of difficult-to-control hypercalcemia. Most of the cases of coexistent MM and PHPT have been observed in females (23 out of 29 reported cases). The youngest patient with codiagnosis was a 45-year-old female and the oldest patient was a 92-year-old female. PHPT is more common in females, whereas the opposite is true for MM. Differences in incidence of the two diseases may explain female preponderance (MM less frequent than PHPT). Initial diagnosis was highly variable, eleven cases had primary diagnosis of hyperparathyroidism, ten had primary diagnosis of MM and seven had both diagnosis made at presentation. The type of immunoglobulin chains of MM observed in all the cases was variable as six patients had light chain MM, remaining patients had a combination of heavy and light chain MM, one patient had nonsecretory type of MM. All the patients had calcium ≥11 mg/dL at the time of presentation. Majority of patients had parathyroid adenoma as a cause of PHPT, few had chief cell hyperplasia, and none had parathyroid cancer. Parathyroidectomy, combination of radiotherapy, and chemotherapy had been used for treatment of this coexistent condition with variable success. Rao et al. \[[@B19]\] suggested that parathyroidectomy in patients with coexistent PHPT and MM serves three folds; first, it removes confusion about etiology of hypercalcemia; second, it alters prognosis of myeloma; third, calcium can be used as a tumor marker in cases if there is a recurrence of tumor. Considering age, our patient was not a candidate for surgery, in such patient population medical alternative to parathyroidectomy is needed. Ten out of 29-patients died within 5 years after codiagnosis, and out of those ten, eight died within one year.

4. Conclusions {#sec4}
==============

A search for concomitant cause of hypercalcemia should be pursued in cases of difficult-to-control hypercalcemia and in elderly individuals, in whom the incidence of PTHP and MM is common.

![MRI demonstrating lytic lesions.](CRIM.ONCMED2013-420565.001){#fig1}

![Mildly hypercellular bone marrow with plasmacytosis (30%), consistent with multiple myeloma.](CRIM.ONCMED2013-420565.002){#fig2}

![Skeletal survey showing lytic lesions in long bones and skulls.](CRIM.ONCMED2013-420565.003){#fig3}

  Result name                            Results                                     Reference range
  -------------------------------------- ------------------------------------------- ------------------
  WBC                                    2.9 K/mm cu                                 4.2--11.0
  Platelet                               156 K/mm cu                                 140--400
  Hemoglobin Hb                          9.0 g/dL                                    12.0--15.0
  Hematocrit                             27.1%                                       36.0--47.0
  Reticulocyte                           0.7%                                        0.5--2.8
  Blood urea nitrogen                    22 mg/dL                                    5--20
  Creatinine                             1.11 mg/dL                                  0.0--1.00
  Sodium                                 143 mmol/L                                  135--145
  Potassium                              4.0 mmol/L                                  3.4--5.1
  Chloride                               104 mmol/L                                  98--109
  Bicarbonate                            33 mmol/L                                   23--31
  Calcium                                13.3 mg/dL                                  8.4--10.5
  Total protein                          7.0 g/dL                                    6.4--8.3
  Albumin                                4.0 g/dL                                    3.4--5.2
  Aspartate amino transferase            20 IU/L                                     0--32
  Alanine amino transferase              10 IU/L                                     0--40
  Alkaline phosphatase                   67 IU/L                                     35--104
  Bilirubin total                        0.2 mg/dL                                   0--10.0
  Haptoglobin                            157 mg/dL                                   36--195
  Vitamin B12                            532 pg/mL                                   211--946
  TSH                                    1.160 uIU/mL                                0.400--5.400
  Vitamin D25 OH                         47.0 ng/mL                                  30.0--100.0
  25 Hydroxy D3                          26 pg/mL                                     
  25 hydroxy D2                          \<8                                          
  Vitamin D 1,25(OH)2                    26                                          18--72
  Folate                                 \>20.0 ng/mL                                3.1--17.5
  Ferritin                               64 ng/mL                                    13--150
  Phosphorous                            2.8 mg/dL                                   2.0--4.0
  Lactate dehydrogenase                  137 IU/L                                    135--214
  Total iron                             30 ug/dL                                    30--160
  Unsaturated IBC                        234.0 ug/dL                                 110.0--370.0
  Total IBC                              264.0                                       228.0--428.0
  Percentage of iron saturation          11%                                         20--55
  PTH intact on day of presentation      70.5 pg/mL                                  15.0--65.0
  PTH 7 months later                     540.0 pg/mL                                  
  PTH-related protein                    18 pg/mL                                    14--27
  Beta-2 microglobulin                   3.3 mg/L (5.8 mg/L four months later)       0.8--2.2
  Serum viscosity                        1.5 relative to H~2~O                       1.5--1.9
  PT/INR                                 10.6/1.0 sec                                9.211.8/0.9--1.1
  APTT                                   29 sec                                      24--33
  Immunoglobulins                                                                     
   IGA                                   29 mg/dL                                    50--400
   IGG                                   692 mg/dL (1200, 5 months later)            600--1500
   IGM                                   6 mg/dL                                     50--300
   Free kappa light chains               1510                                        3.3--19.4 mg/L
   Free lambda light chains              2.4                                         5.7--26.3
   Free Kappa/lambda                     629.17                                      0.26--1.65
  Urine protein electrophoresis                                                       
   Urine volume 24 hours                 1150 mL/24 hour                              
   Urine-protein electrophoresis (UPE)   253 mg/24 hour                              0--165
   Albumin UPE                           30.6%                                        
   Alpha1                                16.1%                                        
   Alpha2                                14.1%                                        
   Beta                                  17.1%                                        
   Gamma                                 22.1%                                        
   Immunofixation                        Free kappa light chains                      
   24-hour-urine protein                 310.5 mg/24 hour                            0--150
   24-hours-urine creatinine             0.7 g/24 hour                               0.74--1.57
   24-hour-urine volume                  1150 cc                                      
   24-hour-urine creatinine              0.5 g/24 hour                               0.74--1.57
   24-hour-urine volume                  900 mL (repeat test)                         
   24-hour-urine calcium                 239 mg/24 hour                              100--300
  Serum protein electrophoresis                                                       
   Albumin                               3.3 g/dL                                    3.1--5.0
   Alpha 1                               0.3 g/dL                                    0.2--0.5
   Alpha2                                0.7 g/dL                                    0.5--1.1
   Beta                                  0.6 g/dL                                    0.6--1.1
   Gamma                                 1.5 g/dL                                    0.7--1.7
   Albumin/globulin                      1.0                                          
   M spike                               1.09 g/dL                                    
   Total protein                         6.5 g/dL                                    6.4--8.3
   Immunofixation                        Monoclonal paraprotein of class IgG kappa   
   CD56 NK cells                         63%                                         3--35
   CD 138 marker                         26%                                          
   Lambda B-cell marker                  1%                                          1--7
   Kappa B-cell marker                   73%                                         2--14%
   CD45 LCA                              98%                                         92--100
   CD38 Marker                           26%                                         1--17

*Pathology.* Normal female bone marrow karyotype. No clonal, structural, or numerical chromosome abnormalities identified. FISH analysis indicates normal hybridization signals with MM probe panel. This excludes majority of chromosome rearrangements known to be associated with MM.

*Surgical Pathology.* Mildly hyper cellular bone marrow with plasmacytosis consistent with MM.

*Leukemia/lymphoma panel*. Bone marrow aspirate shows 30--40% plasma cells with kappa light chain restrictions. (plasma cell dyscrasia).

*Peripheral Smear.* Lymphocytes with foamy cytoplasm, no rouleaux formation, adequate polys with occasional platelet clumps.

  *n*   Author                                                                                                                                                                                            Age/ Gender   Type of MM   Ca (mg/dL)     Therapy for MM and PHPT                                                                                                        Parathyroid histology   Outcome               Initial diagnosis
  ----- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------- ------------ -------------- ------------------------------------------------------------------------------------------------------------------------------ ----------------------- --------------------- -------------------
  1     Pest et al. \[[@B12]\]                                                                                                                                                                            76 F          IgA-?        13.2           Hydration, bisphosphonates, Lasix, melphalan, cyclophosphamide, and steroids                                                   Adenoma                 Survived              PHPT
  2     Rao et al. \[[@B19]\]                                                                                                                                                                             54 M          IgG-lambda   11.2           Adriamycin, melphalan, prednisone, cyclophosphamide, and parathyroidectomy                                                     Adenoma                 Died after 12 years   Both
  3     Jackson and Orland \[[@B20]\]                                                                                                                                                                     45 F          IgG-lambda   17.1           Hydration, Lasix, prednisone, and melphalan                                                                                    Adenoma                 ---                   MM
  4     Chisholm et al. \[[@B21]\]                                                                                                                                                                        80 M          Kappa        13.1           Parathyroidectomy, radiotherapy, melphalan, prednisone, vincristine, carmustine, cyclophosphamide, hydration, and Lasix        Adenoma (c-cells)       Died 2 years later    PHPT
  5     Francis et al. \[[@B22]\]                                                                                                                                                                         70F           Lambda       11.6           Norethisterone, vincristine, melphalan, and prednisone                                                                         Adenoma                 Died 3 weeks later    PHPT
  6     Mundis and kyle \[[@B23]\]                                                                                                                                                                        76 F          IgG-kappa    11.0           Melphalan, prednisone, and parathyroidectomy                                                                                   Adenoma (c-cells)       survived              MM
  7     Stone et al. \[[@B24]\]                                                                                                                                                                           47 F          IgA-kappa    13.7           Melphalan, prednisone, radiotherapy, parathyroidectomy, hydration, and mithramycin                                             Adenoma                 Died                  MM
  8     Hoelzer and Silverberg \[[@B25]\]                                                                                                                                                                 51 F          IgA-lambda   11.9           Parathyroidectomy?                                                                                                             Adenoma (c-cells)       ---                   PHPT
  9     Schneider and Thomas \[[@B26]\]                                                                                                                                                                   74 F          IgG-kappa    12.0           Melphalan, prednisone, and parathyroidectomy                                                                                   Adenoma                 Survived              MM
  10    Toussirot et al. \[[@B27]\]                                                                                                                                                                       82 M          Kappa        15.2           Melphalan, prednisone, and parathyroidectomy                                                                                   Hyperplasia             Died                  PHPT
  11    Goto et al. \[[@B28]\]                                                                                                                                                                            73 F          Kappa        13.2           Parathyroidectomy, melphalan                                                                                                   Adenoma                 Died 1 year later     PHPT
  12    Otsuka et al. \[[@B29]\]                                                                                                                                                                          77 F          IgG-lambda                  Melphalan, prednisone, bisphosphonates, calcitonin, and parathyroidectomy                                                      c-cells hyperplasia     Survived              ---
  13    Fery-Blanco et al. \[[@B30]\]                                                                                                                                                                     68 F          IgG-kappa    11.28          ? chemotherapy and surgery refused                                                                                             Adenoma                 Died                  Both
  14    Sarfati et al. \[[@B31]\]                                                                                                                                                                         62 F          IgA-kappa    16.4           Mithramycin, lasix, plasmaphoresis, Adriamycin, vincristine, prednisone, and parathyroidectomy                                 Adenoma                 Survived              MM
  15    Rosen et al. \[[@B32]\]                                                                                                                                                                           81 M          IgG-kappa    13.4           Hydration, bisphosphonates, melphalan, prednisone, radiotherapy, needle aspiration of parathyroid gland, and refused surgery   Adenoma                 Survived              MM
  16    Tomon et al. \[[@B33]\]                                                                                                                                                                           60 F          IGA-kappa    ---            ---                                                                                                                            ---                     ---                   MM
  17    Fanari et al. \[[@B34]\]                                                                                                                                                                          59 F          lambda       12.7           Hydration, bisphosphonates, cinacalcet, bortezomib and dexamethasone                                                           Possible Adenoma        Died 4 months later   Both
  18    Bogas et al. \[[@B35]\]                                                                                                                                                                           72 F          IgG-kappa    13.66          Melphalan, prednisone, and Interferon?                                                                                         Adenoma                 Died 4 years later    Both
  19    Katayama et al. \[[@B36]\]                                                                                                                                                                        50 F                                                                                                                                                                                                                   PHPT
  20    Romagnoli et al. \[[@B37]\]                                                                                                                                                                       70 F          ---          ---            Parathyroidectomy, steroids and chemotherapy                                                                                   Adenoma                 ---                   PHPT (MEN-1)
  21    Toh and Winocour et al. \[[@B38]\]                                                                                                                                                                71 M                       12.0           Melphalan, prednisone, and bisphosphonates                                                                                                             Died 6 weeks later    MM
  22    Sope$\overset{\sim}{\text{n}}$a et al. \[[@B39]\]                                                                                                                                                 77 F          Kappa (ns)   12.9           Bisphosphonates, refused surgery, or chemotherapy                                                                                                      Died 1 year later     Both
  23    Khandwala and Boctor \[[@B40]\]                                                                                                                                                                   72 F          ---          11.7/ 16.6\*   Parathyroidectomy, bisphosphonates, calcitonin, melphalan, and prednisone                                                      Adenoma                 ---                   PHPT
  24    Patel et al. \[[@B41]\]                                                                                                                                                                           73 F          IgG- kappa   13.5           Bisphosphonates, steroids, thalidomide, plicamycin, and parathyroidectomy                                                      Adenoma                 ---                   MM
  25    Avcioglu et al. \[[@B42]\]                                                                                                                                                                        52 F          IgG-kappa    12.6           Parathyroidectomy and steroids                                                                                                 Adenoma                 ---                   Both
  26    Chowdhury and Scarsbrook et al. \[[@B43]\]                                                                                                                                                        87 F          ---          ---            ---                                                                                                                            ---                     ---                   PHPT
  27    Dalgleish and Gatenby \[[@B44]\]                                                                                                                                                                  59 F          IgG-lambda   11.68          Hydration, lasix, prednisone, mithramycin, cyclophosphamide, and parathyroidectomy                                             Adenoma                 Survived              MM
  28    Peters et al. \[[@B45]\]                                                                                                                                                                          73 M          IgA-lambda   16             Parathyroidectomy, chemotherapy, and radiotherapy                                                                              Hyperplasia             Died 1 week later     PHPT
  29    Our case                                                                                                                                                                                          92 F          IgG-kappa    13 .3          Bisphosphonates, Lasix, hydration, calcitonin, melphalan, prednisone, lenalidomide, and dexamethasone                          ---                     Survived              Both
  30    Johansson and Werner \[[@B16]\] mentioned 3 cases of MM and PHPT (no detail of the cases is given), one other such as has been described by Drezner and Lebovitz \[[@B9]\] without much detail.                                                                                                                                                                                                                          

\*Calcium at time of diagnosis of MM.
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